I agree that this site is using cookies. You can find further informations here.
X
Homicsko, Krisztian
73  results:
Search for persons X
?
1

Patient-derived mini-colons enable long-term modeling of tu..:

Lorenzo-Martín, L. Francisco ; Broguiere, Nicolas ; Langer, Jakob...
Nature Biotechnology.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

Nanoplasmonic Single‐Tumoroid Microarray for Real‐Time Secr..:

Liu, Yen‐Cheng ; Ansaryan, Saeid ; Tan, Jiayi...
Advanced Science.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Response and Resistance to Trametinib in MAP2K1-Mutant Trip..:

Krebs, Fanny Seraphine ; Moura, Bianca ; Missiaglia, Edoardo...
International Journal of Molecular Sciences.  24 (2023)  5 - p. 4520 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity res..:

Tichet, Mélanie ; Wullschleger, Stephan ; Chryplewicz, Agnieszka...
Immunity.  56 (2023)  1 - p. 162-179.e6 , 2023
Link: https://doi.org/10.1016/..
 
?
5

A neutrophil response linked to tumor control in immunother..:

Gungabeesoon, Jeremy ; Gort-Freitas, Nicolas A. ; Kiss, Máté...
Cell.  186 (2023)  7 - p. 1448-1464.e20 , 2023
Link: https://doi.org/10.1016/..
 
?
6

PD-1-expressing macrophages and CD8 T cells are independent..:

Homicsko, Krisztian ; Zygoura, Panagiota ; Norkin, Maxim...
Journal for ImmunoTherapy of Cancer.  11 (2023)  10 - p. e007585 , 2023
Link: https://doi.org/10.1136/..
 
?
7

Deep and lasting response and acquired resistance to BRAFV6..:

Anchisi, Sandro ; Wolfer, Anita ; Bisig, Bettina...
Cancer Biology & Therapy.  24 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
8

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequen..:

Aedo-Lopez, Veronica ; Gérard, Camille L. ; Boughdad, Sarah...
Cancers.  14 (2022)  5 - p. 1162 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Sphingolipids control dermal fibroblast heterogeneity:

Capolupo, Laura ; Khven, Irina ; Lederer, Alex R....
Science.  376 (2022)  6590 - p. , 2022
Link: https://doi.org/10.1126/..
 
?
10

Estimated Costs of the Ipilimumab–Nivolumab Therapy and Rel..:

Gautron Moura, Bianca ; Gerard, Camille ; Testart, Nathalie...
Cancers.  15 (2022)  1 - p. 31 , 2022
Link: https://doi.org/10.3390/..
 
?
11

Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipi..:

Homicsko, Krisztian ; Dummer, Reinhard ; Hoeller, Christoph...
Cancers.  14 (2022)  9 - p. 2300 , 2022
Link: https://doi.org/10.3390/..
 
?
12

First communication on the efficacy of combined177Lutetium-..:

Digklia, Antonia ; Boughdad, Sarah ; Homicsko, Krisztian...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005383 , 2022
Link: https://doi.org/10.1136/..
 
?
13

Aberrant hyperexpression of the RNA binding protein FMRP in..:

Zeng, Qiqun ; Saghafinia, Sadegh ; Chryplewicz, Agnieszka...
Science.  378 (2022)  6621 - p. , 2022
Link: https://doi.org/10.1126/..
 
?
14

Cancer cell autophagy, reprogrammed macrophages, and remode..:

Chryplewicz, Agnieszka ; Scotton, Julie ; Tichet, Mélanie...
Cancer Cell.  40 (2022)  10 - p. 1111-1127.e9 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Ovarian cancer with high-level focal ERBB2 amplification re..:

Thouvenin, Laure ; Charrier, Mélinda ; Clement, Sophie...
Gynecologic Oncology Reports.  37 (2021)  - p. 100787 , 2021
Link: https://doi.org/10.1016/..
 
1-15